Suppr超能文献

在原发性伽玛刀放射外科治疗后,对进行性前庭神经鞘瘤重复立体定向放射外科治疗。

Repeat stereotactic radiosurgery for progressive vestibular schwannomas after primary gamma knife radiosurgery.

机构信息

School of Medicine, University of Pittsburgh Medical Center, Pennsylvania, PA, USA.

Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pennsylvania, PA, 15213, USA.

出版信息

J Neurooncol. 2024 Sep;169(3):591-599. doi: 10.1007/s11060-024-04761-9. Epub 2024 Jul 29.

Abstract

PURPOSE

Limited data provides guidance on the management of vestibular schwannomas (VSs) that have progressed despite primary Gamma Knife radiosurgery (GKRS). The present article reports our long-term experience after repeat GKRS for VS with sustained progression after solely primary GKRS management.

METHODS

A retrospective review of 1997 patients managed between 1987 and 2023 was conducted. Eighteen patients had sustained tumor progression after primary GKRS and underwent repeat GKRS. The median repeat GKRS margin dose was 11 Gy (IQR: 11-12), the median tumor volume was 2.0 cc (IQR: 1.3-6.3), and the median cochlear dose in patients with preserved hearing was 3.9 Gy (IQR: 3-4.1). The median time between initial and repeat GKRS was 65 months (IQR: 38-118).

RESULTS

The median follow-up was 70 months (IQR: 23-101). After repeat GKRS, two patients had further tumor progression at 4 and 21 months and required partial resection of their tumors. The 10-year actuarial tumor control rate after repeat GKRS was 88%. Facial nerve function was preserved in 13 patients who had House-Brackmann grade 1 or 2 function at the time of repeat GKRS. Two patients with serviceable hearing preservation (Gardner-Robertson grade 1 or 2) at repeat GKRS retained that function afterwards. In patients with tinnitus, vestibular dysfunction, and trigeminal neuropathy, symptoms remained stable or improved for 16/16 patients, 12/15 patients, and 10/12 patients, respectively. One patient developed facial twitching in the absence of tumor growth 21 months after repeat GKRS.

CONCLUSIONS

Repeat GKRS effectively controlled tumor growth and preserved cranial nerve outcomes in most patients whose VS had sustained progression after initial primary radiosurgery.

摘要

目的

关于原发性伽玛刀放射外科(GKRS)治疗后仍持续进展的前庭神经鞘瘤(VS)的治疗,目前仅有有限的数据提供指导。本研究报告了我们在仅接受原发性 GKRS 治疗后,对 VS 进行重复 GKRS 治疗以控制持续进展的长期经验。

方法

对 1997 例患者(1987 年至 2023 年期间接受治疗)进行回顾性分析。18 例患者在原发性 GKRS 后肿瘤持续进展,行重复 GKRS 治疗。重复 GKRS 的中位边缘剂量为 11 Gy(IQR:11-12),中位肿瘤体积为 2.0 cc(IQR:1.3-6.3),有听力保留的患者的耳蜗剂量中位数为 3.9 Gy(IQR:3-4.1)。初始 GKRS 与重复 GKRS 之间的中位时间为 65 个月(IQR:38-118)。

结果

中位随访时间为 70 个月(IQR:23-101)。在重复 GKRS 后,2 例患者在 4 个月和 21 个月时肿瘤进一步进展,需要进行肿瘤部分切除术。重复 GKRS 后 10 年肿瘤控制的 actuarial 率为 88%。在重复 GKRS 时面神经功能为 House-Brackmann 1 级或 2 级的 13 例患者中,面神经功能得以保留。2 例在重复 GKRS 时具有可保留听力(Gardner-Robertson 1 级或 2 级)的患者随后保留了该功能。在有耳鸣、前庭功能障碍和三叉神经神经病的患者中,16/16 例、12/15 例和 10/12 例患者的症状分别保持稳定或改善。1 例患者在重复 GKRS 后 21 个月出现面部抽搐,但无肿瘤生长。

结论

在原发性 GKRS 治疗后 VS 持续进展的大多数患者中,重复 GKRS 有效地控制了肿瘤生长,并保留了颅神经的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1311/11341587/43383240d1f6/11060_2024_4761_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验